US-based manufacturer of polymer-based delivery system technologies and formulations Skinvisible Inc has agreed to merge with Quoin Pharmaceuticals Limited.

Quoin Pharmaceuticals develops products to address societal issues such as opioid epidemic and military veteran suicide rate.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Quoin shareholders will hold 72.5% and Skinvisible shareholders will hold 27.5% stake in the newly formed firm Quoin Pharmaceuticals Inc.

“Quoin shareholders will hold 72.5% and Skinvisible shareholders will hold 27.5% stake in the newly formed firm Quoin Pharmaceuticals Inc.”

Avista Capital Partners has agreed to acquire United BioSource Corp (UBC), a company based in the US, from Express Scripts Holding Co for an undisclosed sum.

Also based in the US, UBC is a healthcare company that offers pharmaceutical support services.

The acquired company is a private equity firm that intends to strengthen its footprint in the healthcare sector through the acquisition.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact